These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26123681)

  • 21. Crystallization from Supersaturated Solutions: Role of Lecithin and Composite Simulated Intestinal Fluid.
    Indulkar AS; Gao Y; Raina SA; Zhang GGZ; Taylor LS
    Pharm Res; 2018 Jun; 35(8):158. PubMed ID: 29916053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement.
    Murdande SB; Pikal MJ; Shanker RM; Bogner RH
    Pharm Dev Technol; 2011 Jun; 16(3):187-200. PubMed ID: 20429826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amorphous Drug Solubility and Maximum Free Drug Concentrations in Cyclodextrin Solutions: A Quantitative Study Using NMR Diffusometry.
    Ueda K; Higashi K; Moribe K
    Mol Pharm; 2021 Jul; 18(7):2764-2776. PubMed ID: 34180226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compromised in vitro dissolution and membrane transport of multidrug amorphous formulations.
    Alhalaweh A; Bergström CAS; Taylor LS
    J Control Release; 2016 May; 229():172-182. PubMed ID: 27006280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase separation of supersaturated solution created from amorphous solid dispersions: Relevance to oral absorption.
    Kawakami K; Sato K; Fukushima M; Miyazaki A; Yamamura Y; Sakuma S
    Eur J Pharm Biopharm; 2018 Nov; 132():146-156. PubMed ID: 30253186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceutical Perspective on Opalescence and Liquid-Liquid Phase Separation in Protein Solutions.
    Raut AS; Kalonia DS
    Mol Pharm; 2016 May; 13(5):1431-44. PubMed ID: 27017836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic and Thermodynamic Interplay of Polymer-Mediated Liquid-Liquid Phase Separation for Poorly Water-Soluble Drugs.
    Qian K; Stella L; Liu F; Jones DS; Andrews GP; Tian Y
    Mol Pharm; 2024 Jun; 21(6):2878-2893. PubMed ID: 38767457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mathematical model to analyze the dissolution behavior of metastable crystals or amorphous drug accompanied with a solid-liquid interface reaction.
    Hirai D; Iwao Y; Kimura SI; Noguchi S; Itai S
    Int J Pharm; 2017 Apr; 522(1-2):58-65. PubMed ID: 28235625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct NMR Monitoring of Phase Separation Behavior of Highly Supersaturated Nifedipine Solution Stabilized with Hypromellose Derivatives.
    Ueda K; Higashi K; Moribe K
    Mol Pharm; 2017 Jul; 14(7):2314-2322. PubMed ID: 28558250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Refining stability and dissolution rate of amorphous drug formulations.
    Grohganz H; Priemel PA; Löbmann K; Nielsen LH; Laitinen R; Mullertz A; Van den Mooter G; Rades T
    Expert Opin Drug Deliv; 2014 Jun; 11(6):977-89. PubMed ID: 24754747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin particle formation in supersaturated aqueous solutions of poly(ethylene glycol).
    Bromberg L; Rashba-Step J; Scott T
    Biophys J; 2005 Nov; 89(5):3424-33. PubMed ID: 16254391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In situ molecular elucidation of drug supersaturation achieved by nano-sizing and amorphization of poorly water-soluble drug.
    Ueda K; Higashi K; Yamamoto K; Moribe K
    Eur J Pharm Sci; 2015 Sep; 77():79-89. PubMed ID: 26036231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly supersaturated solutions of amorphous drugs approaching predictions from configurational thermodynamic properties.
    Matteucci ME; Miller MA; Williams RO; Johnston KP
    J Phys Chem B; 2008 Dec; 112(51):16675-81. PubMed ID: 19367943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the impact of polymers on the pH-induced precipitation behavior of poorly water soluble compounds using synchrotron wide angle X-ray scattering.
    Hsieh YL; Box K; Taylor LS
    J Pharm Sci; 2014 Sep; 103(9):2724-2735. PubMed ID: 24504566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wetting Kinetics: an Alternative Approach Towards Understanding the Enhanced Dissolution Rate for Amorphous Solid Dispersion of a Poorly Soluble Drug.
    Verma S; Rudraraju VS
    AAPS PharmSciTech; 2015 Oct; 16(5):1079-90. PubMed ID: 25672820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liquid-Liquid Phase Separation in a Dual Variable Domain Immunoglobulin Protein Solution: Effect of Formulation Factors and Protein-Protein Interactions.
    Raut AS; Kalonia DS
    Mol Pharm; 2015 Sep; 12(9):3261-71. PubMed ID: 26237070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liquid-liquid phase separation drug aggregate: Merit for oral delivery of amorphous solid dispersions.
    Zhao P; Han W; Shu Y; Li M; Sun Y; Sui X; Liu B; Tian B; Liu Y; Fu Q
    J Control Release; 2023 Jan; 353():42-50. PubMed ID: 36414193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of supersaturation of amorphous pharmaceuticals: nonlinear rate of supersaturation generation regulated by matrix diffusion.
    Sun DD; Lee PI
    Mol Pharm; 2015 Apr; 12(4):1203-15. PubMed ID: 25775257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stabilizing supersaturated drug-delivery system through mechanism of nucleation and crystal growth inhibition of drugs.
    Joshi P; Sangamwar AT
    Ther Deliv; 2018 Nov; 9(12):873-885. PubMed ID: 30444454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase Behavior of Resveratrol Solid Dispersions Upon Addition to Aqueous media.
    Wegiel LA; Mosquera-Giraldo LI; Mauer LJ; Edgar KJ; Taylor LS
    Pharm Res; 2015 Oct; 32(10):3324-37. PubMed ID: 25975588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.